|
1
|
Li T, Mello-Thoms C and Brennan PC:
Descriptive epidemiology of breast cancer in China: Incidence,
mortality, survival and prevalence. Breast Cancer Res Treat.
159:395–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Sauer AG, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei YT, Guo DW, Hou XZ and Jiang DQ:
miRNA-223 suppresses FOXO1 and functions as a potential tumor
marker in breast cancer. Cell Mol Biol (Noisy-le-grand).
63:113–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li P, Xu T, Zhou X, Liao L, Pang G, Luo W,
Han L, Zhang J, Luo X, Xie X and Zhu K: Downregulation of miRNA-141
in breast cancer cells is associated with cell migration and
invasion: Involvement of ANP32E targeting. Cancer Med. 6:662–672.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhuang Q, Shen J, Chen Z, Zhang M, Fan M,
Xue D, Lu H, Xu R, He X and Hou J: miR-337-3p suppresses the
proliferation and metastasis of clear cell renal cell carcinoma
cells via modulating Capn4. Cancer Biomark. 23:515–525. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zuo XL, Chen ZQ, Wang JF, Wang JG, Liang
LH and Cai J: miR-337-3p suppresses the proliferation and invasion
of hepatocellular carcinoma cells through targeting JAK2. Am J
Cancer Res. 8:662–674. 2018.PubMed/NCBI
|
|
8
|
Cao XM: Role of miR-337-3p and its target
Rap1A in modulating proliferation, invasion, migration and
apoptosis of cervical cancer cells. Cancer Biomark. 24:257–267.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du P, Zeng H, Xiao Y, Zhao Y, Zheng B,
Deng Y, Liu J, Huang B, Zhang X and Yang K: Chronic stress promotes
EMT-mediated metastasis through activation of STAT3 signaling
pathway by miR-337-3p in breast cancer. Cell Death Dis. 11:7612020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Y, Shen JK, Hornicek FJ, Kan Q and
Duan Z: The emerging roles and therapeutic potential of
cyclin-dependent kinase 11 (CDK11) in human cancer. Oncotarget.
7:40846–40859. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tong W, Han TC, Wang W and Zhao J: LncRNA
CASC11 promotes the development of lung cancer through targeting
microRNA-302/CDK1 axis. Eur Rev Med Pharmacol Sci. 23:6539–6547.
2019.PubMed/NCBI
|
|
12
|
Piao J, Zhu L, Sun J, Li N, Dong B, Yang Y
and Chen L: High expression of CDK1 and BUB1 predicts poor
prognosis of pancreatic ductal adenocarcinoma. Gene. 701:15–22.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sung WW, Lin YM, Wu PR, Yen HH, Lai HW, Su
TC, Huang RH, Wen CK, Chen CY, Chen CJ and Yeh KT: High
nuclear/cytoplasmic ratio of Cdk1 expression predicts poor
prognosis in colorectal cancer patients. BMC Cancer. 14:9512014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tian Z, Cao S, Li C, Xu M, Wei H, Yang H,
Sun Q, Ren Q and Zhang L: LncRNA PVT1 regulates growth, migration,
and invasion of bladder cancer by miR-31/ CDK1. J Cell Physiol.
234:4799–4811. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W, Cho H, Shin HY, Chung JY, Kang ES,
Lee EJ and Kim JH: Accumulation of cytoplasmic Cdk1 is associated
with cancer growth and survival rate in epithelial ovarian cancer.
Oncotarget. 7:49481–49497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Izadi S, Nikkhoo A, Hojjat-Farsangi M,
Namdar A, Azizi G, Mohammadi H, Yousefi M and Jadidi-Niaragh F:
CDK1 in breast cancer: Implications for theranostic potential.
Anticancer Agents Med Chem. 20:758–767. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wilhite SE and Barrett T: Strategies to
explore functional genomics data sets in NCBI's GEO database.
Methods Mol Biol. 802:41–53. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al: An integrated TCGA pan-cancer clinical data resource to
drive high-quality survival outcome analytics. Cell.
173:400–416.e411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nagy Á, Munkácsy G and Győrffy B:
Pancancer survival analysis of cancer hallmark genes. Sci Rep.
11:60472021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu B, Liu G, Jin Y, Yang T, Zhang D, Ding
L, Zhou F, Pan Y and Wei Y: miR-15b-5p promotes growth and
metastasis in breast cancer by targeting HPSE2. Front Oncol.
10:1082020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
ELife. 12:e050052015. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang D, Zhao L, Peng C, Ran K, Mu R and Ao
Y: LncRNA CRNDE promotes hepatocellular carcinoma progression by
upregulating SIX1 through modulating miR-337-3p. J Cell Biochem.
120:16128–16142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Q, Huang Q, Cheng S, Wu S, Sang H and
Hou J: Circ_ZNF124 promotes non-small cell lung cancer progression
by abolishing miR-337-3p mediated downregulation of JAK2/STAT3
signaling pathway. Cancer Cell Int. 19:2912019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Menon DR, Luo Y, Arcaroli JJ, Liu S,
KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan AC, et
al: CDK1 Interacts with Sox2 and promotes tumor initiation in human
melanoma. Cancer Res. 78:6561–6574. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Kang W, Lu X, Ma S, Dong L and
Zou B: LncRNA CASC11 promoted gastric cancer cell proliferation,
migration and invasion in vitro by regulating cell cycle pathway.
Cell Cycle. 17:1886–1900. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie D, Song H, Wu T, Li D, Hua K, Xu H,
Zhao B, Wu C, Hu J, Ji C, et al: MicroRNA-424 serves an
anti-oncogenic role by targeting cyclin-dependent kinase 1 in
breast cancer cells. Oncol Rep. 40:3416–3426. 2018.PubMed/NCBI
|
